Ramy Farid - 29 May 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol
VIR
Transactions as of
29 May 2024
Net transactions value
$0
Form type
4
Filing time
31 May 2024, 14:43:18 UTC
Previous filing
05 Mar 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +16,000 $0.000000 16,000 29 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 29 May 2024 Common Stock 16,000 $10.10 Direct F1
transaction VIR Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 29 May 2024 Common Stock 16,000 $10.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter.
F2 Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders.